Castellum Inc (CTM) Stock Analysis
Verdict: WATCH (do not buy)
Persistent dilution and unprofitability overshadow revenue growth; insider buying at $0.61 provides a floor, but no catalyst for $3 targets.
Investment score: 44/100
Analysis as of
Is Castellum Inc stock worth reviewing? The TradeMates thesis
CTM is a high-growth, unprofitable micro-cap with strong government exposure but a history of heavy dilution. Hold for potential 2026 pivot to profitability.
7-factor investment score
- Valuation: 40/100 (weight 20%)
- Financial Health: 45/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 38/100 (weight 15%)
- Insider Sentiment: 65/100 (weight 10%)
- Analyst Consensus: 55/100 (weight 10%)
- Risk-Adjusted Return: 40/100 (weight 15%)
Castellum Inc opportunities and risks
What speaks for CTM
- Projected 2026 Pivot to Profitability
What speaks against CTM
- Aggressive Share Dilution History
Peers and competitors
- BNAI
- CSPI
- RSSS
- EAXR
- XTIA
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CTM | n/a | 1.2x | 1274.4x | 35.8% | -2.8% | 2.2% |
| BNAI | n/a | 158.9x | n/a | -1052.1% | -2186.1% | -10.4% |
| CSPI | n/a | 1.4x | n/a | 32.7% | -0.2% | -6.4% |
| RSSS | 15.8x | 1.5x | 9.9x | 50.1% | 9.3% | 7.7% |
| EAXR | 821.4x | 18.7x | 312.2x | 79.1% | 2.3% | -0.8% |
| XTIA | n/a | 0.5x | n/a | 19.6% | -183.5% | -134.3% |
| Peer median | n/a | 1.5x | n/a | 32.7% | -0.2% | -6.4% |
Frequently asked questions about Castellum Inc (CTM)
Is CTM stock a good investment?
The TradeMates model rates Castellum Inc as WATCH (do not buy) with an investment score of 44/100. CTM is a high-growth, unprofitable micro-cap with strong government exposure but a history of heavy dilution. Hold for potential 2026 pivot to profitability. This is algorithmic model output, not personal investment advice.
Is CTM stock a buy?
The TradeMates model verdict for CTM is WATCH (do not buy) with an investment score of 44/100. Treat this as a model signal to review, not a personal buy recommendation.